Jon Beauchamp

Jon Beauchamp has extensive work experience in the pharmaceutical and biotechnology industries. Jon held various leadership positions at companies such as argenx, Nutrinia, and GYROSCOPE Tx. At argenx, they served as the Vice President, Medical Affairs and played a key role in the Efgartigimod Asset Strategy Team. Jon also led the EU Medical Affairs department and served as the Country Manager for the UK and Ireland. Prior to argenx, Jon worked as the Senior Vice President of European Operations at Nutrinia and as the Interim Chief Operating Officer at GYROSCOPE Tx. Jon has also worked as an Independent Consultant for early-stage rare disease biotechnology companies and served as an EU Market Access consultant at Orchard Therapeutics. Before transitioning to the pharmaceutical industry, Jon worked as a doctor in various hospitals, including the Royal London Hospital, Homerton Hospital, and Royal Prince Alfred Hospital in Sydney.

Jon Beauchamp attended Tupton Hall Secondary School from 1988 to 1995. Jon then pursued a Bachelor of Medicine, Bachelor of Surgery (MBBS) degree in Medicine at St Bartholomew's and The Royal London Medical School from 1995 to 2001.